Navigation Links
IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
Date:11/2/2007

M study and the potential for UVIDEM as a treatment for melanoma. Actual results may differ materially from the forward-looking statements due to a number of important factors, including, but not limited to, whether the Company or any of its collaborators will be able to develop pharmaceutical products using the technologies of the Company, whether clinical trial results to date are predictive of results of any future clinical trials, risks associated with completing clinical trials of product candidates, risks involved in the regulatory approval process for the Company's product candidates, the possibility that clinical testing may reveal undesirable and unintended side effects or other characteristics that may prevent or limit the commercial use of proposed products; whether the cash resources of the Company will be sufficient to fund operations as planned, including any further clinical trials of any of the Company's product candidates, and the Company's dependence on intellectual property. These factors and others affecting the Company's business are more fully discussed in the Company's Annual Report on Form 10-Q filed with the SEC for the quarter ended June 30, 2007 and other periodic reports filed with the SEC. The Company expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law.


'/>"/>
SOURCE IDM Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015 Point-of-Care Partners, a ... consulting firm, has launched the ePA State Navigator ... IT vendors, payers and pharmacies to quickly assess ... authorization (ePA) of prescription medications. Today, ... are completed through time-consuming, manual processes amongst prescribers, ...
(Date:3/31/2015)... ROCHELLE, N.Y. , March 31, 2015 /PRNewswire-USNewswire/ ... it will be featured in the American Medical ... by ITN Productions. AMGA,s "High Performing ... on the challenges facing the nation,s healthcare system ... Medical Letter is profiled along with other leading ...
(Date:3/31/2015)... March 31, 2015 RnRMarketResearch.com ... market research report of 68 pages with latest ... intelligence library. The report "Pemphigus - Pipeline Review, ... therapeutic development for Pemphigus , complete with ... drug target, mechanism of action (MoA), route of ...
Breaking Medicine Technology:Point-of-Care Partners Launches the ePA State Navigator 2AMGA's High Performing Health News Program Features The Medical Letter 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4
... , , ... Inc.,("Chindex") (Nasdaq: CHDX ), a leading independent American provider of ... that the Company will attend the 21st Annual Piper Jaffray,"Unplugged" Health ... the,New York Palace Hotel. , Management is ...
... SAN DIEGO, Nov. 24 Anadys Pharmaceuticals, Inc. (Nasdaq: ... 21st Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, ... conference is being held at The New York Palace Hotel. ... Anadys, will provide an overview of Anadys and its clinical ...
Cached Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2
(Date:4/1/2015)... 01, 2015 Decora Preset 30 Minute Countdown ... on ‘The Hardware City.’ The product helps in automatically switching ... time and the related electronic device is automatically turned off ... the company said, “We are glad that this amazing product ... buy Countdown Timer Switch in just a few clicks. The ...
(Date:4/1/2015)... Results are in for the fifth annual ... new homes from across the state exemplifying high-efficiency design. ... building techniques and new technology intended to lower energy ... (SWA) provided sustainability consulting services for 4 of the ... first- and third-place winners. , The Benker Residence, a ...
(Date:3/31/2015)... Due to its rapid expansion, ... caregivers, staffing personnel, and marketing managers, franchise sales ... the Greater Los Angeles area. In line with ... University has firmed up its training program and ... quality in-home care through a client-centered and service-oriented ...
(Date:3/31/2015)... 31, 2015 Over the last several ... technique have yielded better results and more efficient ... and perfected by a good hair transplant surgeon, has ... techniques of hair restoration have improved the efficiency of ... used to add precision and flexibility to the field ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 In ... (ADS) is offering advice for buying from a ... Dealers Association (NMEDA) is a nonprofit organization that ... in the manufacturing and installation of mobility equipment. ... in the industry that consistently adhere to the ...
Breaking Medicine News(10 mins):Health News:Leviton Decora Preset 30 Minute Countdown Timer Available On TheHardwareCity.com 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 3Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 4Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 2Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 3Health News:Beverly Hills Hair Transplant Surgeon Now Combines Advanced Robotic Hair Transplantation and Manual Techniques for Greatest Results 2Health News:Advanced Driving Systems Celebrates National Disability Month 2
... that diet soda doesn,t protect against metabolic syndrome , , ... heavy in meat, fried foods and refined grains puts ... collection of risk factors for heart problems, stroke and ... findings confirmed previous research with one interesting twist: Drinking ...
... childhood obesity epidemic could undo gains, heart association says ... Association goals to reduce deaths from heart disease and ... a worrisome lack of progress against such intractable health ... -- could render those gains short-lived, the heart association ...
... STE ) today announced that its Board of ... of $0.06 per common share. The,dividend is payable March ... business on February 12, 2008., About STERIS, ... healthier today and,safer tomorrow through knowledgeable people and innovative ...
... sexual orientation , , TUESDAY, Jan. 22 (HealthDay News) -- ... romantic relationships as heterosexual couples, find two studies ... Psychology . , The authors of the studies ... aren,t as healthy or secure as heterosexual pairings. , ...
... Interactions , Researchers have undertaken a ... amyloid precursor protein (APP), a protein centrally associated ... of Alzheimer,s is the extracellular accumulation of amyloid ... from the cleavage of APP, which generates short, ...
... 2007, Weinheim, DE: Wiley-Blackwell, the scientific, technical, medical ... Sons, Inc., published a comprehensive resource for students ... Proteins are essential components of all living cells, ... of each cell and, ultimately, the entire organism. ...
Cached Medicine News:Health News:Another Study Links Western Diet to Heart, Health Risks 2Health News:Another Study Links Western Diet to Heart, Health Risks 3Health News:U.S. Deaths Down From Heart Disease, Stroke 2Health News:U.S. Deaths Down From Heart Disease, Stroke 3Health News:STERIS Corporation Declares Regular Quarterly Dividend 2Health News:STERIS Corporation Declares Regular Quarterly Dividend 3Health News:Same-Sex Couples Just as Committed as Heterosexual Counterparts 2Health News:Story ideas from Molecular and Cellular Proteomics 2Health News:'The Handbook of Proteins' 2
... latest 3-part differential analyzer based on the ... the CELL-DYN line. Offering 18 parameters and ... CELL-DYN 1800 meets the needs to today's ... than its predecessors and fits under standard ...
... produces high-quality blood films. Smearing parameters have ... time, eliminating the need to make adjustments ... hematocrit values. In the closed sampling mode, ... and aspirates only 200L. Only 30L of ...
... InstaCheck® Menopause Predictor Test is an in ... FSH in urine. Changes in FSH levels ... symptoms associated with stages of menopause. The ... obtain a visual, qualitative result and is ...
... diabetes continue to have a tremendous impact ... of patients, in addition to the significant ... be associated with elevated levels of blood ... haemoglobin A1c (HbA1c) in a diabetic patient's ...
Medicine Products: